These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12132559)

  • 21. A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).
    Kalaitzakis E; Björnsson E
    Ther Clin Risk Manag; 2007 Aug; 3(4):653-63. PubMed ID: 18472988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esomeprazole: A significant advance beyond omeprazole in the treatment of acid-related disease.
    Rabasseda X; Cole P
    Drugs Today (Barc); 2001 Nov; 37(11):767-781. PubMed ID: 12738973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.
    Edwards SJ; Lind T; Lundell L
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1729-36. PubMed ID: 11683686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials.
    Gralnek IM; Dulai GS; Fennerty MB; Spiegel BM
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1452-8. PubMed ID: 17162239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
    Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis: comparison of esomeprazole and other proton pump inhibitors in eradicating Helicobacter pylori.
    Wang X; Fang JY; Lu R; Sun DF
    Digestion; 2006; 73(2-3):178-86. PubMed ID: 16837803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
    Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis.
    Lightdale CJ; Schmitt C; Hwang C; Hamelin B
    Dig Dis Sci; 2006 May; 51(5):852-7. PubMed ID: 16773434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-isomer drugs: true therapeutic advances.
    Andersson T
    Clin Pharmacokinet; 2004; 43(5):279-85. PubMed ID: 15080761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
    Tolia V; Gilger MA; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Esomeprazole in treating duodenal ulcer in various modes of anti-Helicobacter therapy].
    Maev IV; Kurilo AE; V'iuchnova ES; Shchekina MI
    Ter Arkh; 2003; 75(2):23-6. PubMed ID: 12685385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch.
    Asghar W; Pittman E; Jamali F
    Daru; 2015 Nov; 23():50. PubMed ID: 26573220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):279-87. PubMed ID: 11950384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis.
    Gisbert JP; Pajares JM
    Dig Liver Dis; 2004 Apr; 36(4):253-9. PubMed ID: 15115337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.
    Guimarães EV; Guerra PV; Penna FJ
    Ther Clin Risk Manag; 2010 Oct; 6():531-7. PubMed ID: 21063463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of esomeprazole, compared with omeprazole, in maintenance therapy for reflux esophagitis -a phase III, multicenter, randomized, double-blind trial-].
    Kinoshita Y; Miwa H; Kasugai K
    Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1428-38. PubMed ID: 23912002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.